Gradient Investments »

Halozyme Therapeutics shares owned by Gradient Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Gradient Investments from 13F filings

Historical chart of Gradient Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Gradient Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Gradient Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 16k 78.27

More positions owned by Gradient Investments

Spdr Series Trust St Str P500etf (SPYM)
NVIDIA Corporation (NVDA)
Doubleline Etf Trust Mortgage Etf (DMBS)
Apple (AAPL)
Amazon (AMZN)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Alphabet Cap Stk Cl C (GOOG)
Janus Detroit Str Tr Henderson Mtg (JMBS)
World Gold Tr Spdr Gld Minis (GLDM)
Aim Etf Products Trust Allianzim Us Equ (SEPU)
Microsoft Corporation (MSFT)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Columbia Etf Tr I Resh Enhnc Cor (RECS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Ishares U S Etf Tr U.s. Tech Indepd (IETC)

View all positions for Gradient Investments

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Alliancebernstein

View all funds holding Halozyme Therapeutics